English
简体中文
Total: £ 56.28
2026-03-20 | Pages: 105 | Tables: 107
The global HIV Prevention Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-20 | Pages: 116 | Tables: 112
The global Biologics for Severe Asthma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-03-20 | Pages: 115 | Tables: 111
The global TROP2-ADC Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This ...
2026-03-20 | Pages: 108 | Tables: 114
The global Monoclonal Antibody to Thymic Stromal Lymphopoietin (TSLP) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertain...
2026-03-20 | Pages: 121 | Tables: 122
The global Anti-Histone H3 Antibodies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-03-20 | Pages: 126 | Tables: 127
The global Anti-HMGB1 Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-20 | Pages: 119 | Tables: 121
The global Anti-c-Myc Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-20 | Pages: 110 | Tables: 113
The global Anti-Beta Catenin Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-03-20 | Pages: 122 | Tables: 127
The global Drugs for ES-SCLC market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Th...
2026-03-20 | Pages: 122 | Tables: 127
The global Treatment of Extensive-stage Small Cell Lung Cancer market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into...
2026-03-20 | Pages: 94 | Tables: 96
The global BCMA/CD3 Bispecific Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-03-20 | Pages: 93 | Tables: 91
The global BCMA/CD3 Targeted Biological Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-03-20 | Pages: 106 | Tables: 100
The global IL-4Rα Monoclonal Antibody Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic...
2026-03-20 | Pages: 91 | Tables: 93
The global Dupilumab Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-20 | Pages: 121 | Tables: 123
The global IL-4Rα Targeting Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscap...
